10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001638833-21-000114`
Period End Date	20210331
Filing Date	20210505
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	sgry-20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 96 Income Statement 59 Cash Flow Statement 64 Stockholders Equity 25 Comprehensive Income 10

Balance Sheet 96 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$189.30M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$215.60M	USD	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$317.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$541.90M	USD	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$382.20M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$367.00M	USD	Point-in-time
Inventories	`InventoryNet`	$56.40M	USD	Point-in-time
Inventories	`InventoryNet`	$56.10M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$434.50M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$439.70M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.60M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$21.10M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.40M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$31.70M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$801.50M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.02B	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $215.6 and $189.3, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$544.30M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $215.6 and $189.3, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$544.60M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.52B	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.51B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$90.40M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$90.30M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	50.46M	shares	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$305.40M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$310.10M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	59.90M	shares	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$124.80M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	59.90M	shares	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$127.40M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$27.00M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$36.20M	USD	Point-in-time
Total assets	`Assets`	$5.41B	USD	Point-in-time
Total assets	`Assets`	$5.64B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$100.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$96.00M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$67.30M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$65.40M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$109.00M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$109.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$241.30M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$217.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$61.20M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$64.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$574.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$556.80M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.79B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.79B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$300.90M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$295.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$139.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$126.10M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$306.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$321.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$315.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$308.20M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $439.7 and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$439.70M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $439.7 and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$434.50M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 59,898,730 and 50,461,706, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 59,898,730 and 50,461,706, respectively	`CommonStockValueOutstanding`	$600.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$607.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$843.30M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-61.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-54.60M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-431.80M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-452.80M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$336.50M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$115.60M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$766.50M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$768.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.64B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.41B	USD	Point-in-time

Income Statement 59 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$441.00M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$512.40M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$140.40M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$151.70M	USD	1 Quarter
Supplies	`SuppliesExpense`	$147.30M	USD	1 Quarter
Supplies	`SuppliesExpense`	$129.30M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$55.50M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$46.80M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.30M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$22.80M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$31.60M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$28.40M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$408.90M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$366.20M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$26.80M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$22.80M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$21.80M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.00M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.60M	USD	1 Quarter
(Gain) loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$900.00K	USD	1 Quarter
(Gain) loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-3.50M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$5.50M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$5.30M	USD	1 Quarter
Grant funds	`GrantRevenue`	-	USD	1 Quarter
Grant funds	`GrantRevenue`	$15.10M	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-1.20M	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-46.00M	USD	Annual
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	$-1.50M	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	-	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$448.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$417.50M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$23.50M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$64.30M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-53.30M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-47.10M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$11.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-23.60M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$200.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-15.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-8.40M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$10.80M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$19.10M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$31.80M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-27.50M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-21.00M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$10.30M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$9.50M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-37.00M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.30M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.76	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.57	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.57	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.76	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.77M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.47M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.47M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.77M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-8.40M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$10.80M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$21.80M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-1.30M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-1.60M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$5.20M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$3.50M	USD	1 Quarter
(Gain) loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$900.00K	USD	1 Quarter
(Gain) loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-3.50M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-100.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-15.50M	USD	1 Quarter
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-500.00K	USD	1 Quarter
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$200.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$9.80M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$9.40M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-15.50M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.90M	USD	1 Quarter
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-7.20M	USD	1 Quarter
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	-	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$2.40M	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-1.60M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$29.20M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$50.20M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.50M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.80M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.10M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$5.50M	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$2.30M	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$9.40M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-200.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-14.30M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.70M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$16.60M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$52.80M	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$158.40M	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$600.00K	USD	1 Quarter
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.10M	USD	1 Quarter
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	$260.90M	USD	1 Quarter
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	1 Quarter
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	$12.60M	USD	1 Quarter
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	1 Quarter
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$5.10M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$24.00M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$31.30M	USD	1 Quarter
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromMinorityShareholders`	$1.00M	USD	1 Quarter
Receipts (payments) related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$400.00K	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-800.00K	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-8.00M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.40M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$187.80M	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$223.70M	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$101.90M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$194.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$541.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$194.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$541.90M	USD	Point-in-time

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	59.90M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$100.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-13.90M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-2.80M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.30M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.50M	USD	1 Quarter
Equity offering	`StockIssuedDuringPeriodValueNewIssues`	$248.30M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$2.30M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$700.00K	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$14.90M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.80M	USD	1 Quarter
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	59.90M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time

Comprehensive Income 10 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-8.40M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$10.80M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-33.60M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$17.20M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$19.10M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$31.80M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-52.70M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-14.60M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.